Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis

A Blauvelt; K Reich; R B Warren; J C Szepietowski; B Sigurgeirsson; S K Tyring; I Messina; V Bhosekar; J Oliver; C Papavassilis; J Frueh; R G B Langley

doi:10.1111/bjd.15656

Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis

A Blauvelt, K Reich, R B Warren, J C Szepietowski, B Sigurgeirsson, S K Tyring, I Messina, V Bhosekar, J Oliver, C Papavassilis, J Frueh, R G B Langley

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	879-881
Number of pages	3
Journal	The British journal of dermatology
Volume	177
Issue number	3
DOIs	https://doi.org/10.1111/bjd.15656
Publication status	Published - Sept 2017

Keywords

Letter

Access to Document

10.1111/bjd.15656

Cite this

Blauvelt, A., Reich, K., Warren, R. B., Szepietowski, J. C., Sigurgeirsson, B., Tyring, S. K., Messina, I., Bhosekar, V., Oliver, J., Papavassilis, C., Frueh, J., & Langley, R. G. B. (2017). Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis. The British journal of dermatology, 177(3), 879-881. https://doi.org/10.1111/bjd.15656

@article{8bf3fe1a58fd45cb94376d8801b961b5,

title = "Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis",

keywords = "Letter",

author = "A Blauvelt and K Reich and Warren, {R B} and Szepietowski, {J C} and B Sigurgeirsson and Tyring, {S K} and I Messina and V Bhosekar and J Oliver and C Papavassilis and J Frueh and Langley, {R G B}",

year = "2017",

month = sep,

doi = "10.1111/bjd.15656",

language = "English",

volume = "177",

pages = "879--881",

journal = "The British journal of dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "3",

}

Blauvelt, A, Reich, K, Warren, RB, Szepietowski, JC, Sigurgeirsson, B, Tyring, SK, Messina, I, Bhosekar, V, Oliver, J, Papavassilis, C, Frueh, J & Langley, RGB 2017, 'Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis', The British journal of dermatology, vol. 177, no. 3, pp. 879-881. https://doi.org/10.1111/bjd.15656

TY - JOUR

T1 - Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis

AU - Blauvelt, A

AU - Reich, K

AU - Warren, R B

AU - Szepietowski, J C

AU - Sigurgeirsson, B

AU - Tyring, S K

AU - Messina, I

AU - Bhosekar, V

AU - Oliver, J

AU - Papavassilis, C

AU - Frueh, J

AU - Langley, R G B

PY - 2017/9

Y1 - 2017/9

KW - Letter

U2 - 10.1111/bjd.15656

DO - 10.1111/bjd.15656

M3 - Letter

C2 - 28498514

SN - 0007-0963

VL - 177

SP - 879

EP - 881

JO - The British journal of dermatology

JF - The British journal of dermatology

IS - 3

ER -